Yue Yin Xia

No ORCID on file · 1 paper in corpus
review 2022
Hereditary cancer in clinical practice ·doi:10.1186/s13053-022-00227-z

BRCA1 and BRCA2 mutation carriers face an elevated lifetime risk of developing ovarian cancer. Oral contraceptives have been shown to significantly decrease the risk of ovarian cancer by approximately 50% in this high-risk population. Chang…